Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Allergic reaction warning for OTC vaginal contraceptives proposed by FDA in TFM.

This article was originally published in The Tan Sheet

Executive Summary

OTC VAGINAL CONTRACEPTIVE ALLERGIC REACTION WARNING is proposed by FDA in a tentative final monograph published in the Feb. 3 Federal Register. "Consumers should be warned about possible allergic reactions such as burning and itching that may occur when using" vaginal contraceptives, the agency said. FDA added that the warning should also advise consumers to discontinue use of the product if such reactions occur.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel